0001323885-22-000063.txt : 20220527 0001323885-22-000063.hdr.sgml : 20220527 20220527085440 ACCESSION NUMBER: 0001323885-22-000063 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220525 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220527 DATE AS OF CHANGE: 20220527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AtriCure, Inc. CENTRAL INDEX KEY: 0001323885 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 341940305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-51470 FILM NUMBER: 22972758 BUSINESS ADDRESS: STREET 1: 7555 INNOVATION WAY CITY: MASON STATE: OH ZIP: 45040 BUSINESS PHONE: 513-755-4100 MAIL ADDRESS: STREET 1: 7555 INNOVATION WAY CITY: MASON STATE: OH ZIP: 45040 8-K 1 atrc-20220525.htm 8-K atrc-20220525
0001323885False00013238852022-05-252022-05-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) of the
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 25, 2022
AtriCure, Inc.
(Exact name of registrant as specified in charter)
Delaware
000-51470
34-1940305
(State or other jurisdiction of
incorporation)
(Commission File Number)
(IRS Employer Identification No.)
7555 Innovation Way, Mason OH 45040
(Address of Principal Executive Offices, and Zip Code)
(513) 755-4100
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.001 par valueATRCNASDAQ
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
At the AtriCure, Inc. (the “Company”) Annual Meeting of Stockholders which was held on May 25, 2022, the stockholders of the Company approved the AtriCure, Inc. 2014 Stock Incentive Plan Amended and Restated as of May 25, 2022 (the “2014 Plan”). The 2014 Plan was previously approved and amended to increase the number of shares available by the Board of Directors subject to stockholder approval. The 2014 Plan was amended to increase the number of shares of common stock available for issuance under it from 5,250,000 to 6,350,000.
The objectives of the 2014 Plan are to provide long-term incentives to those persons with responsibility for the success and growth of the Company, to motivate participants to achieve the long-term success and growth of the Company, to provide a vehicle to tie a significant portion of compensation to the long-term performance of the Company’s shares, to enable the Company to attract and retain skilled and qualified officers, other employees, directors and consultants who are expected to contribute to the Company’s success in a competitive market for such individuals, to facilitate ownership of the Company’s shares and to align the personal interests of officers, employees and others in the Company’s long-term growth and profitability with the interests of the Company’s stockholders. The 2014 Plan is an “omnibus” stock plan that provides for a variety of equity award vehicles to maintain flexibility. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted share awards, restricted share units and unrestricted share awards. The 2014 Plan does not permit the re-pricing of options or stock appreciation rights without the approval of stockholders and does not contain an “evergreen” provision to automatically increase the number of shares issuable under the 2014 Plan, except for certain adjustments resulting from stock splits and other specified events.
The foregoing summary of the 2014 Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the 2014 Plan filed as an exhibit to this report.
Item 5.07.    Submission of Matters to a Vote of Security Holders.
The stockholders of the Company voted on four items at the Annual Meeting of Stockholders held on May 25, 2022:
1.The election of nine directors to serve one-year terms expiring at the 2023 Annual Meeting of Stockholders and until their successors have been duly elected and qualified;
2.A proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.The approval of an amendment to the AtriCure, Inc. 2014 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,100,000; and
4.An advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement.
The nominees for director were elected based upon the following votes:
Director NomineesForAgainstAbstainBroker Non-Votes
Michael H. Carrel39,816,6141,331,58153,9782,156,025
Mark A. Collar40,320,568825,96655,6392,156,025
Regina E. Groves40,706,059445,37350,7412,156,025
B. Kristine Johnson39,517,2651,634,16050,7482,156,025
Karen N. Prange40,682,019467,85352,3012,156,025
Deborah H. Telman41,130,07919,79352,3012,156,025
Sven A. Wehrwein40,699,449447,18455,5402,156,025
Robert S. White40,702,372444,19055,6112,156,025
Maggie Yuen41,129,45820,41352,3022,156,025



The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 received the following votes:
For:42,797,787 
Against:510,460 
Abstain:49,951 
Broker Non-Votes:
The approval of an amendment to the AtriCure, Inc. 2014 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,100,000 received the following votes:
For:39,199,184 
Against:1,951,981 
Abstain:51,008 
Broker Non-Votes:2,156,025 
The advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement received the following votes:
For:39,728,864 
Against:1,415,119 
Abstain:58,190 
Broker Non-Votes:2,156,025 
Item 9.01    Financial Statements and Exhibits.
(d)Exhibits
No.Description
10.1
104Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ATRICURE, INC.
Dated:May 27, 2022By:/s/ Angela L. Wirick
Angela L. Wirick
Chief Financial Officer

EX-10.1 2 exhibit101-2014stockincent.htm EX-10.1 Document
Exhibit 10.1
ATRICURE, INC.
2014 STOCK INCENTIVE PLAN
(AMENDED AND RESTATED AS OF MAY 25, 2022)



TABLE OF CONTENTS
1Purposes1
2Definitions1
3Administration of the Plan3
(a)Authority of Committee3
(b)Binding Authority4
(c)Delegation of Authority4
4Eligibility4
5Common Shares Subject to the Plan4
(a)Authorized Number of Common Shares4
(b)Share Counting4
(c)Award Limitations.5
(d)Shares to be Delivered5
(e)Minimum Vesting5
6Awards to Participants5
(a)Stock Options.5
(b)Stock Appreciation Rights6
(c)Restricted Shares and Restricted Share Units7
(d)Performance-Based Awards8
(e)Unrestricted Share Awards8
(f)Restricted Share Grants to Non-Employee Directors8
7Deferred Payment9
8Dilution and Other Adjustments9
9Change in Control9
10Termination9
(a)Termination by Death, Disability, or Retirement9
(b)Termination for Cause9
(c)Other Terminations9
(d)Limitation for ISOs10
(e)Transfers and Leaves of Absence10
11Recoupment or Recovery Policy10
12Miscellaneous Provisions10
(a)Rights as a Shareholder10
(b)No Loans10
(c)Assignment or Transfer10
(d)Withholding Taxes10
(e)No Rights to Awards11
(f)Beneficiary Designation11
(g)Fractional Shares11
(h)Unfunded Plan11
(i)Severability11
(j)Limitation of Liability11
(k)Successors11
(l)Code Section 409A Compliance11
13Effective Date, Amendments, Governing Law and Plan Termination11
(a)Effective Date11



(b)Amendments11
(c)Governing Law12
(d)Plan Termination12



ATRICURE, INC.
2014 STOCK INCENTIVE PLAN
(AMENDED AND RESTATED AS OF MAY 25, 2022)
1. Purposes
The purposes of the Plan are to provide long-term incentives to those persons with significant responsibility for the success and growth of the Company, to align the interests of such persons with those of the Company’s shareholders, to assist the Company in recruiting, retaining and motivating employees, directors and consultants on a competitive basis and to link compensation to performance.
2. Definitions
For purposes of the Plan, the following capitalized terms shall have the meanings specified below:
(a) “Affiliate” has the meaning set forth in Rule 12b-2 under the Exchange Act.
(b) “Award” means a grant of Stock Options, Stock Appreciation Rights, Restricted Shares, Restricted Share Units, or unrestricted Common Shares or any or all of them, to a Participant.
(c) “Award Agreement” means an agreement, either in written or electronic format, between the Company and a Participant setting forth the terms and conditions of an Award granted to the Participant.
(d) “Beneficial Owner” has the meaning given in Rule 13d-3 under the Exchange Act.
(e) “Board” means the Board of Directors of the Company.
(f) “Cause” means with respect to any Participant, unless otherwise provided in the applicable Award Agreement (i) indictment for, conviction of, or plea of guilty or no contest by the Participant to a felony, or of any criminal act, that has an adverse effect on the Participant’s qualifications or ability to perform his duties; (ii) the unreasonable deliberate and material failure or refusal by the Participant to perform his employment duties (other than as a result of PTO, sickness, disability, illness or injury), and the failure to rectify the same within thirty (30) days after the Company shall have given notice to the Participant identifying such failure or refusal and demanding that it be rectified; (iii) the Participant’s commission of any act of fraud, embezzlement, dishonesty or other misconduct that has caused, or would reasonably be expected to cause, material injury or economic harm to the Company; (iv) an act of gross negligence on the part of the Participant that has caused, or would reasonably be expected to cause, material injury or economic harm to the Company; (v) a deliberate and material violation of a written material Company policy; or (vi) a material breach of the Plan or any change-in control or non-disclosure agreement to which Participant and the Company may be parties (or, in each case, any successor thereto or amendment thereof) which (and only if the same shall be curable) Participant fails to cure within thirty (30) days after the Company shall have given notice to the Participant identifying such breach and demanding that it be cured. Any purported termination by the Company for Cause which does not satisfy the applicable requirements of this Section 2(f) shall be conclusively deemed to be a termination by the Company without Cause for purposes of the Plan.
(g) “Change in Control” means the occurrence of any of the following events:
(i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities;
(ii) The consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets;
(iii) A change in the composition of the Board occurring within a two-year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” means directors who either (A) are directors as of the effective date of the Plan, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company); or
(iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the
1


surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
Notwithstanding anything herein to the contrary, and only to the extent that an Award is subject to Code Section 409A and payment of the Award pursuant to the application of the definition of “Change in Control” above would cause such Award not to otherwise comply with Code Section 409A, payment of an Award may occur upon a Change in Control only to the extent that the event constitutes a “change in the ownership or effective control” of the Company or a “change in the ownership of a substantial portion of the assets” of the Company under Code Section 409A.
(h) “Code” means the Internal Revenue Code of 1986, as amended, and any rules, regulations or guidance promulgated thereunder. Any reference to the Code or a section thereof shall also refer to any successor Code or section.
(i) “Committee” means a committee appointed by the Board consisting of at least three members of the Board, all meeting the definitions of “outside director” set forth in Code Section 162(m) (as in effect prior to amendment by the Tax Cuts and Jobs Act) and Treasury Department regulations thereunder, “independent director” set forth in The Nasdaq Stock Market rules, and “non-employee director” set forth in Rule 16b-3 of the Exchange Act, or any successor definitions adopted for a similar purpose by the Internal Revenue Service, any national securities exchange on which the Common Shares are listed or the Securities and Exchange Commission.
(j) “Common Share” or “Common Shares” means one or more of the shares of common stock, par value $.001, of the Company.
(k) “Company” means AtriCure, Inc., a corporation organized under the laws of the State of Delaware, its subsidiaries, divisions and affiliated businesses.
(l) “Date of Grant” means the date on which the Committee authorizes the grant of an Award or such later date as may be specified by the Committee in such authorization.
(m) “Disability” means total and permanent disability as defined in Section 22(e)(3) of the Code, provided that in the case of Awards other than ISOs, the Committee in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Committee from time to time.
(n) “Effective Date” has the meaning set forth in Section 13(a).
(o) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and any rules, regulations, schedules or guidance promulgated thereunder. Any reference to the Exchange Act or a section thereof shall also refer to any successor Exchange Act or section.
(p) “Exercise Price” means the purchase price of a Common Share covered by a Stock Option or SAR, as applicable.
(q) “Fair Market Value” on any date means the closing price of the Common Shares as reported on The Nasdaq Stock Market or, if applicable, any other national securities exchange on which the Common Shares are principally traded, or, if there were no sales of Common Shares on such date, then on the immediately preceding date on which there were any sales of Common Shares. If the Common Shares cease to be traded on a national securities exchange, the Fair Market Value shall be determined pursuant to a reasonable valuation method prescribed by the Committee. In the case of an ISO (or Tandem SAR), Fair Market Value shall be determined by the Committee in accordance with Code Section 422. For Awards intended to be exempt from Code Section 409A, Fair Market Value shall be determined by the Committee in accordance with Code Section 409A.
(r) “Full-Value Award” means Restricted Shares, Restricted Share Units or unrestricted Common Shares.
(s) “ISO” means an Incentive Stock Option satisfying the requirements of Code Section 422 and designated as an ISO by the Committee.
(t) “Non-Employee Director” means a member of the Board who is not an employee of the Company.
(u) “NQSO” means a non-qualified Stock Option that does not satisfy the requirements of Code Section 422 or that is not designated as an ISO by the Committee.
(v) “Participant” means a person eligible to receive an Award under the Plan, as set forth in Section 4, and designated by the Committee to receive an Award subject to the conditions set forth in the Plan and any Award Agreement.
(w) “Performance Goals” means the goals established by the Committee, as described in Section 6(d)(ii).
(x) “Performance Measures” means the criteria set out in Section 6(d)(iii) that may be used by the Committee as the basis for a Performance Goal.
2


(y) “Performance Period” means the period established by the Committee during which the achievement of Performance Goals is assessed in order to determine whether and to what extent an Award that is conditioned on attaining Performance Goals has been earned.
(z) “Person” shall have the meaning given in Section 3(a)(9) of the Exchange Act, except that such term shall not include (i) the Company or any of its Affiliates, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its subsidiaries, (iii) an underwriter temporarily holding securities pursuant to an offering of such securities or (iv) a corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of Company securities.
(aa) “Plan” means the AtriCure, Inc. 2014 Stock Incentive Plan, as amended and restated from time to time.
(bb) “Prior Plan” means the AtriCure, Inc. 2005 Equity Incentive Plan, as it may have been amended and restated.
(cc) “Restricted Shares” means Common Shares that are subject to restrictions, as described in Section 6(c).
(dd) “Restricted Share Units” means a right, as described in Section 6(c), denominated in Common Shares to receive an amount, payable in either cash, Common Shares, Restricted Shares, or a combination thereof, equal to the value of a specified number of Common Shares.
(ee) “Restriction Period” means, with respect to any Full-Value Award, the period during which any risk of forfeiture or other restrictions set by the Committee, including performance restrictions, remain in effect until such time as they have lapsed under the terms and conditions of the Full-Value Award or as otherwise determined by the Committee.
(ff) “Retirement” means: retirement with the Company at or after age 65.
(gg) “Securities Act” means the Securities Act of 1933, as amended, and any rules, regulations, schedules or guidance promulgated thereunder. Any reference to the Securities Act or a section thereof shall also refer to any successor Securities Act or section.
(hh) “Stock Appreciation Right” or “SAR” means the right, as described in Section 6(b), to receive a payment equal to the excess of the Fair Market Value of a Common Share on the date the SAR is exercised over the Exercise Price established for that SAR at the time of grant, multiplied by the number of Common Shares with respect to which the SAR is exercised.
(ii) “Stock Option” means the right, as described in Section 6(a), to purchase Common Shares at a specified price for a specified period of time. Stock Options include ISOs and NQSOs.
(jj) “Tandem SAR” means a SAR granted in tandem with a Stock Option.
3. Administration of the Plan
(a) Authority of Committee. The Plan shall be administered by the Committee. Unless otherwise determined by the Board, the Compensation Committee of the Board shall serve as the Committee. The Committee shall have all the powers vested in it by the terms of the Plan, such powers to include the sole and exclusive authority to (within the limitations described in the Plan):
(i) select Participants to be granted Awards under the Plan and grant Awards pursuant to the terms of the Plan;
(ii) determine the type, size and terms of the Awards to be granted to each Participant;
(iii) determine the time when Awards are to be granted and any conditions that must be satisfied before an Award is granted;
(iv) establish objectives and conditions for earning an Award;
(v) determine all other terms and conditions, not inconsistent with the terms of the Plan and any operative employment or other agreement, of any Award granted under the Plan, and determine the appropriate Award Agreement evidencing the Award;
(vi) determine whether the terms, conditions, and objectives for earning an Award have been met, including, without limitation, any such determination or certification, as the case may be, required for compliance with Code Section 162(m)(as in effect prior to its amendment by the Tax Cuts and Jobs Act);
(vii) modify or waive the terms and conditions of Awards granted under the Plan, not inconsistent with the terms of the Plan and any operative employment or other agreement, accelerate the vesting, exercise or payment of an
3


Award or cancel or suspend an Award; provided, however, that the Committee shall have the ability to accelerate the vesting of an Award only upon a Change in Control, pursuant to Section 5(e), or the death or Disability of a Participant;
(viii) determine whether the amount or payment of an Award should be reduced or eliminated, and determine if, when and under what conditions payment of all or any part of any Award may be deferred;
(ix) determine the guidelines and/or procedures for the payment or exercise of Awards;
(x) determine whether any Awards granted to an employee should have Performance Goals or Performance Measures;
(xi) adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan and establish and administer any sub-plans that may be governed by the Plan;
(xii) construe, interpret, administer and implement the Plan, any Award Agreements or related documents and correct any defect, supply an omission or reconcile any inconsistency in or between the Plan, any Award Agreement or related documents; and
(xiii) make factual determinations with respect to the Plan and any Awards and otherwise supervise the administration of the Plan.
(b) Binding Authority. The Committee’s interpretations of the Plan, and all actions taken and determinations made by the Committee pursuant to the powers vested in it under the Plan, shall be conclusive and binding on all parties, including the Company, its shareholders and all Participants.
(c) Delegation of Authority. To the extent not prohibited by law or the rules of the national securities exchange on which the Company’s Common Shares are listed, the Committee may allocate its authority hereunder to one or more of its members or delegate its authority hereunder to one or more Non-Employee Directors, and may grant authority to employees of the Company to execute documents on behalf of the Committee or to otherwise assist in the administration and operation of the Plan. The Committee may delegate, on such terms and conditions as it determines in its sole discretion, to the Company’s Chief Executive Officer, with the required approval of the Company’s Chief Financial Officer or Senior Vice President, Human Resources, the authority to grant Awards to Participants (other than to the Chief Executive Officer, members of the Board of Directors and officers who report directly to the Chief Executive Officer, including any officers who are subject to Section 16 of the Exchange Act) and the authority to make all necessary and appropriate decisions and determinations with respect thereto. In no event shall the Committee authorize any officer to designate an officer delegated authority under the Plan as a recipient of any Awards.
4. Eligibility
Subject to the terms and conditions of the Plan, the Committee may select, from all eligible persons, Participants to whom Awards shall be granted under the Plan and shall determine the nature and amount of each Award. Eligible persons include any of the following individuals: (i) any officer or key employee of the Company, (ii) any consultant (as defined in the General Instructions to the Form S-8 registration statement under the Securities Act) to the Company, and (iii) any Non-Employee Director. All Awards shall be evidenced by an Award Agreement, and Awards may be conditioned upon the Participant’s execution of an Award Agreement.
5. Common Shares Subject to the Plan
(a) Authorized Number of Common Shares. Unless otherwise authorized by the Company’s shareholders and subject to this Section 5 and Section 8, the maximum aggregate number of Common Shares available for issuance under the Plan is 6,350,000, plus (i) the number of Common Shares that, on the Effective Date, are available to be granted under the Prior Plan but which are not then subject to outstanding awards under the Prior Plan, and (ii) the number of Common Shares subject to outstanding awards under the Prior Plan as of the Effective Date which thereafter are forfeited, settled in cash or cancelled or expire. Upon the Effective Date, the Prior Plan will terminate; provided that all outstanding awards under the Prior Plan as of the Effective Date shall remain outstanding and shall be administered and settled in accordance with the provisions of the Prior Plan, as applicable. The maximum number of Common Shares available for issuance with respect to ISOs is 6,350,000.
(b) Share Counting. The following rules shall apply in determining the number of Common Shares available for grant under the Plan:
(i) Common Shares subject to any Award shall be counted against the maximum share limitation as one Common Share for every Common Share subject thereto.
(ii) To the extent that any Award is forfeited, cancelled, settled in cash, returned to the Company for failure to satisfy vesting requirements or other conditions of the Award or otherwise terminates without an issuance of
4


Common Shares being made, the maximum share limitation shall be credited with one Common Share for each Common Share subject to such Award, and such number of credited Common Shares may again be made subject to Awards under the Plan.
(iii) Any Common Shares tendered by a Participant or withheld as full or partial payment of withholding or other taxes or as payment for the exercise or conversion price of an Award or repurchased by the Company with Stock Option proceeds shall not be added back to the number of Common Shares available for issuance under the Plan. Upon exercise of a SAR, the number of Common Shares subject to the Award that are being exercised shall be counted against the maximum aggregate number of Common Shares that may be issued under the Plan on the basis of one Common Share for every Common Share subject thereto, regardless of the actual number of Common Shares used to settle the SAR upon exercise.
(iv) Any Common Shares underlying Awards granted through the assumption of, or in substitution for, outstanding awards previously granted to individuals who become employees of the Company as a result of a merger, consolidation, acquisition or other corporate transaction shall not, unless required by law or regulation, count against the reserve of available Common Shares under the Plan.
(c) Award Limitations. Subject to the adjustment provisions of Section 8:
(i) The maximum aggregate number of Common Shares that may be subject to Stock Options or SARs granted in any calendar year to any one Participant (other than a Non-Employee Director) shall be 6,350,000 Common Shares.
(ii) The maximum aggregate number of Common Shares that may be subject to Full-Value Awards granted in any calendar year to any one Participant (other than a Non-Employee Director) shall be 6,350,000 Common Shares.
(iii) Grants to Non-Employee Directors shall be limited to the grants described in Section 6(f).
(d) Shares to be Delivered. Common Shares to be delivered by the Company under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares.
(e) Minimum Vesting. Except with respect to five percent (5%) of the maximum aggregate number of Shares that may be issued under the Plan, as provided herein, no Award shall vest earlier than one year following the date of grant of such Award; provided, however, that such limitation shall not preclude the acceleration of vesting of such Award upon the death or disability of the Participant or in connection with a Change in Control, as determined by the Committee in its discretion.
6. Awards to Participants
(a) Stock Options.
(i) Grants. Subject to the terms and conditions of the Plan, Stock Options may be granted to Participants, in such number and upon such terms and conditions as the Committee determines, and may consist of ISOs or NQSOs. Stock options may be granted alone or with Tandem SARs. With respect to Stock Options granted with Tandem SARs, the exercise of either such Stock Options or Tandem SARs will result in the simultaneous cancellation of the same number of Stock Options or Tandem SARs, as the case may be.
(ii) Exercise Price. The Exercise Price shall be equal to or, at the Committee’s discretion, greater than the Fair Market Value on the date the Stock Option is granted, unless the Stock Option was granted through the assumption of, or in substitution for, outstanding awards previously granted to individuals who became employees of the Company as a result of a merger, consolidation, acquisition or other corporate transaction, in which case the assumption or substitution shall be accomplished in a manner that permits the Stock Option to be exempt from Code Section 409A.
(iii) Term. The term of Stock Options shall be determined by the Committee in its sole discretion, but in no event shall the term exceed ten years from the Date of Grant.
(iv) ISO Limits. ISOs may be granted only to Participants who are employees of the Company (or of any parent or subsidiary corporation within the meaning of Code Section 424) on the Date of Grant, and may only be granted to an employee who, at the time the Stock Option is granted, does not own more than ten percent of the total combined voting power of all classes of stock of the Company (or of any parent or subsidiary corporation within the meaning of Code Section 424), unless (A) the Exercise Price is at least 110% percent of the Fair Market Value on the Date of Grant, and (B) the ISO is not exercisable after five years from the Date of Grant. The aggregate Fair Market Value of all Common Shares, determined at the time the ISOs are granted, with respect to which ISOs are exercisable by a Participant for the first time during any calendar year (under all plans of the Company) shall not exceed $100,000 or such other
5


amount as may subsequently be specified by the Code. If such Fair Market Value exceeds the $100,000 limit, the ISOs exceeding the limit shall be treated as NQSOs, taking the Stock Options in the order each was granted. The terms of all ISOs shall be consistent with and contain or be deemed to contain all provisions required to qualify as an “incentive stock option” under Code Section 422.
(v) No Repricing. Subject to the adjustment provisions of Section 8, without the approval of the Company’s shareholders, (A) the Exercise Price for any outstanding Stock Option may not be decreased after the Date of Grant, (B) no outstanding Stock Option may be surrendered to the Company as consideration for the grant of a new Stock Option with a lower Exercise Price, and (C) no other modifications to any outstanding Stock Option may be made that would be treated as a “repricing” under the then applicable rules, regulations or listing requirements adopted by the national securities exchange on which the Common Shares are listed. Neither the Board nor the Committee shall offer a cash buy-out of “underwater” Stock Options, and such buyouts of “underwater” Stock Options shall be prohibited.
(vi) Form of Payment. Vested Stock Options may be exercised (at the election of the Participant) in whole or in part, and the Exercise Price shall be paid to the Company at the time of exercise, subject to any applicable rules or regulations adopted by the Committee:
(A) to the extent permitted by applicable law, pursuant to cashless exercise procedures that are approved by the Committee;
(B) through the tender of unrestricted Common Shares owned by the Participant (or by delivering a certification or attestation of ownership of such Common Shares) valued at their Fair Market Value on the date of exercise;
(C) in cash or its equivalent; or
(D) by any combination of (A), (B), and (C) above.
(vii) No Dividends or Shareholder Rights. No dividends or dividend equivalents may be paid on Stock Options. Except as otherwise provided herein, a Participant shall have no rights as a holder of Common Shares covered by a Stock Option unless and until such Common Shares have been registered to the Participant as the owner.
(viii) Other Restrictions. Stock Options may be granted subject to such terms and conditions as the Committee determines, including, without limitation: forfeiture conditions, transfer restrictions, restrictions based upon the achievement of specific Performance Goals (Company-wide, divisional and/or individual) which may be based on one or more Performance Measures, time-based restrictions on vesting and/or restrictions under applicable federal or state securities laws.
(b) Stock Appreciation Rights.
(i) Grants. Subject to the terms and provisions of the Plan, SARs may be granted to Participants, in such number and upon such terms and conditions as the Committee determines, and may be granted alone or as Tandem SARs. With respect to Tandem SARs, the exercise of either such Stock Options or SARs will result in the simultaneous cancellation of the same number of Tandem SARs or Stock Options, as the case may be.
(ii) Exercise Price. The Exercise Price shall be equal to or, at the Committee’s discretion, greater than Fair Market Value on the date the SAR is granted, unless the SAR was granted through the assumption of, or in substitution for, outstanding awards previously granted to individuals who became employees of the Company as a result of a merger, consolidation, acquisition or other corporate transaction involving the Company, in which case the assumption or substitution shall be accomplished in a manner that permits the SAR to be exempt from Code Section 409A.
(iii) Term. The term of a SAR shall be determined by the Committee in its sole discretion, but in no event shall the term exceed ten (10) years from the Date of Grant; provided that, each SAR granted in tandem with a Stock Option shall terminate upon the termination or exercise of the related Stock Option.
(iv) No Repricing. Subject to the adjustment provisions of Section 8, without the approval of the Company’s shareholders, (A) the Exercise Price for any outstanding SAR may not be decreased after the Date of Grant, (B) no outstanding SAR may be surrendered to the Company as consideration for the grant of a new SAR with a lower Exercise Price, and (C) no other modifications to any outstanding SAR may be made that would be treated as a “repricing” under the then applicable rules, regulations or listing requirements adopted by the national securities exchange on which the Common Shares are listed. Neither the Board nor the Committee shall offer a cash buy-out of “underwater” Stock Options, and such buyouts of “underwater” Stock Options shall be prohibited.
6


(v) Form of Payment. Vested SARs may be exercised in whole or in part, and the Committee may authorize payment of a SAR in the form of cash, Common Shares valued at its Fair Market Value on the date of the exercise or a combination thereof, or by any other method as the Committee may determine.
(vi) Tandem SARs. Tandem SARs may be exercised for all or part of the Common Shares subject to the related Stock Option upon the surrender of the right to exercise the equivalent portion of the related Stock Option. A Tandem SAR may be exercised only with respect to the Common Shares for which its related Stock Option is then exercisable. Notwithstanding any other provision of the Plan to the contrary, with respect to a Tandem SAR granted in connection with an ISO: (A) the Tandem SAR will expire no later than the expiration of the underlying ISO; (B) the value of the payout with respect to the Tandem SAR may be for no more than 100% of the excess of the Fair Market Value of the Common Shares subject to the underlying ISO at the time the Tandem SAR is exercised over the Exercise Price of the underlying ISO; and (C) the Tandem SAR may be exercised only when the Fair Market Value of the Common Shares subject to the ISO exceeds the Exercise Price of the ISO.
(vii) No Dividends or Shareholder Rights. No dividends or dividend equivalents may be paid on SARs. Except as otherwise provided herein, a Participant shall have no rights as a holder of Common Shares covered by a SAR unless and until such Common Shares have been registered to the Participant as the owner.
(viii) Other Restrictions. SARs may be granted subject to such terms and conditions as the Committee determines, including, without limitation: forfeiture conditions, transfer restrictions, restrictions based upon the achievement of specific Performance Goals (Company-wide, divisional and/or individual) which may be based on one or more Performance Measures, time-based restrictions on vesting and/or restrictions under applicable federal or state securities laws.
(c) Restricted Shares and Restricted Share Units.
(i) Grants. Subject to the terms and provisions of the Plan, Restricted Shares and Restricted Share Units may be granted to Participants in such number and upon such terms and conditions as the Committee determines. Restricted Shares will be registered in the name of the Participant and deposited with the Company or its agent in certificated or book-entry form.
(ii) Restrictions. Restricted Shares or Restricted Share Units may be granted at no cost or at a purchase price determined by the Committee, which may be less than the Fair Market Value, but subject to such terms and conditions as the Committee determines, including, without limitation: forfeiture conditions, transfer restrictions, restrictions based upon the achievement of specific Performance Goals (Company-wide, divisional and/or individual) which may be based on one or more Performance Measures, time-based restrictions on vesting and/or restrictions under applicable federal or state securities laws. Subject to the other terms and conditions in Sections 5(e), 6, 9, and 10, for Awards to employees, no Restricted Shares or Restricted Share Units conditioned upon the achievement of performance shall be based on a Restriction Period of less than one year, and, except as may be determined by the Committee, any Restriction Period based solely on continued employment or service (time-based) shall be for a minimum of three years, subject to (A) pro rata or graded vesting prior to the expiration of such time-based Restriction Period, and (B) acceleration due to the Participant’s death or Disability or upon a Change in Control, in each case as specified in the applicable Award Agreement.
(iii) Transfer Restrictions. During the Restriction Period, Restricted Shares and Restricted Share Units may not be sold, assigned, transferred or otherwise disposed of, or mortgaged, pledged or otherwise encumbered. In order to enforce the limitations imposed upon the Restricted Shares, the Committee may (A) cause a legend or legends to be placed on any certificates evidencing such Restricted Shares, and/or (B) cause “stop transfer” instructions to be issued, as it deems necessary or appropriate.
(iv) Dividends and Voting Rights. Unless otherwise determined by the Committee, during the Restriction Period, Participants who hold Restricted Shares shall have the right to receive dividends in cash or other property or other distribution or rights in respect of the Restricted Shares and shall have the right to vote the Restricted Shares as the record owners; provided that, any dividends or other property payable to a Participant during the Restriction Period shall be distributed to the Participant only if and when the restrictions imposed on the applicable Restricted Shares lapse. Unless otherwise determined by the Committee, during the Restriction Period, Participants who hold Restricted Share Units shall be credited with dividend equivalents in respect of such Restricted Share Units; provided that, such dividend equivalents shall be distributed (without interest) to the Participant only if and when the restrictions imposed on the applicable Restricted Share Units lapse. Participants shall have no other rights as a shareholder with respect to Restricted Share Units unless otherwise determined by the Committee.
7


(v) Payment of Restricted Share Units. Restricted Share Units that become payable in accordance with their terms and conditions shall be settled in cash, Common Shares, Restricted Shares, or a combination thereof, as determined by the Committee.
(vi) Ownership. Restricted Shares shall be registered in the name of the Participant on the books and records of the Company or its designee (or by one or more physical certificates if physical certificates are issued) subject to the applicable restrictions imposed by the Plan. At the end of the Restriction Period that applies to Restricted Shares, the number of shares to which the Participant is entitled shall be delivered to the Participant free and clear of the restrictions, either in certificated or book-entry form. No Common Shares shall be registered in the name of the Participant with respect to Restricted Share Units, and Participants shall have no ownership interest in the Common Shares to which the Restricted Share Units relate, unless and until payment is made in Common Shares.
(vii) Forfeiture. If a Participant who holds Restricted Shares or Restricted Share Units fails to satisfy the restrictions, terms or conditions applicable to the Award, except as otherwise determined by the Committee, or permitted by Section 5(e), the Participant shall forfeit the Restricted Shares or Restricted Share Units. The Committee may at any time waive such restrictions or accelerate the date or dates on which the restrictions will lapse upon a Change in Control or a Participant’s death or Disability.
(d) Performance-Based Awards.
(i) Grants. Subject to the provisions of the Plan, Full-Value Awards may be conditioned upon the achievement of Performance Goals as the Committee shall determine, in its sole discretion.
(ii) Performance Goals. Performance Goals shall be based on one or more Performance Measures, over a Performance Period, as to be determined by the Committee. Performance Goals shall be objective and shall be established in writing by the Committee not later than 90 days after the beginning of the Performance Period (but in no event after 25% of the Performance Period has elapsed), and while the outcome as to the Performance Goal is substantially uncertain.
(iii) Performance Measures. The Performance Measure(s) may be described in terms of objectives that are related to the individual Participant or objectives that are Company-wide or related to a subsidiary, division, department, region, function or business unit of the Company, and shall consist of one or more or any combination of the following criteria: cash flow, profit, revenue, stock price, market share, sales, net income, operating income, return ratios, earnings per share, compound annual growth rate, earnings (which may include an add back for taxes, interest, and/or depreciation and amortization), operating earnings, profit margins, earnings per Common Share, favorable comparison to established budgets, return on shareholders’ equity, return on assets, attainment of strategic and operational initiatives, comparisons with various stock market indices, reduction in costs or a combination of such factors, personal performance measures, working capital, total assets, net assets, return on sales, return on invested capital, gross margin, costs, shareholders’ equity, shareholder return and/or productivity or productivity improvement. The Performance Goals based on these Performance Measures may be expressed in absolute terms or relative to the performance of other entities.
(iv) Treatment of Awards. With respect to any Full-Value Award that is conditioned upon the achievement of Performance Goals, such Full-Value Award and any dividends or other property otherwise payable with respect to such Full-Value Award shall not vest or be paid until the Committee shall first have certified that the Performance Goals have been achieved.
(e) Unrestricted Share Awards.
(i) Subject to the terms and provisions of the Plan, the Committee may grant awards of unrestricted Common Shares to Participants in such number and upon such terms and conditions as the Committee determines in recognition of outstanding achievements or contributions by such Participants or otherwise. Unrestricted Common Shares issued on a bonus basis may be issued for no cash consideration.
(f) Restricted Share Grants to Non-Employee Directors.
(i) Automatic Grants. Each Non-Employee Director shall automatically be granted (i) Restricted Shares worth $175,000 of Common Shares, as valued on the Date of Grant, upon, or in connection with, commencement of service as a director of the Company, and (ii) Restricted Shares worth $150,000 of Common Shares, as valued on the Date of Grant, at each annual meeting of the Company’s stockholders. All such Restricted Shares shall be subject to the terms and conditions of this Plan.
(ii) Vesting of Restricted Shares Granted to Non-Employee Directors. Each initial grant of Restricted Shares granted to a newly elected or appointed Non-Employee Director shall vest in three (3) successive equal annual installments over the Non-Employee Directors’ period of continued service as a director, with the first such installment to
8


vest upon the Non-Employee Director’s completion of one (1) year of service as a Non-Employee Director measured from the Date of Grant. Each annual grant of Restricted Shares granted to continuing Non-Employee Directors shall vest upon the Non-Employee Director’s completion of one (1) year of service as a Non-Employee Director measured from the Date of Grant.
7. Deferred Payment
Subject to the terms of the Plan, the Committee may determine that all or a portion of any Award to a Participant, whether it is to be paid in cash, Common Shares or a combination thereof, shall be deferred or may, in its sole discretion, approve deferral elections made by Participants. Deferrals shall be for such periods and upon such terms as the Committee may determine in its sole discretion, which terms shall comply with Code Section 409A
8. Dilution and Other Adjustments
In the event of any merger, reorganization, consolidation, liquidation, recapitalization, reclassification, redesignation, stock dividend, other extraordinary distribution (whether in the form of cash, shares or otherwise), stock split, reverse stock split, spin off, combination, repurchase or exchange of shares or issuance of warrants or rights to purchase shares or other securities, or other change in corporate structure affecting the Common Shares, the Committee shall make such adjustments in the aggregate number and type of Common Shares which may be delivered and the individual award maximums as set forth in Section 5, the number and type of Common Shares subject to outstanding Awards and the Exercise Price or other price of Common Shares subject to outstanding Awards (provided the number of Common Shares subject to any Award shall always be a whole number), as may be and to the extent determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan. Such adjustment shall be conclusive and binding for all purposes of the Plan. The Committee shall determine whether and the extent to which any recapitalization, extraordinary distribution, reclassification, repurchase or exchange of shares or other event requires any such adjustment. Any such adjustment of an ISO or SAR shall be made in compliance with Code Sections 422 and 424, and no such adjustment shall be made that would cause any Award which is or becomes subject to Code Section 409A to fail to comply with the requirements of Code Section 409A or is exempt from Code Section 409A to become subject to Code Section 409A.
9. Change in Control
Notwithstanding any other provision of the Plan to the contrary, immediately upon the occurrence of a Change in Control, the following provisions of this Section 9 shall apply except to the extent that (i) the applicable Award is assumed or an equivalent option or right substituted by the successor corporation or a parent or subsidiary of the successor corporation; or (ii) an Award Agreement provides for a different treatment (in which case the Award Agreement shall govern):
(a) all outstanding Stock Options and SARs vest and become fully exercisable; and
(b) all Full-Value Awards become fully vested and all Performance Goals or other vesting criteria will be deemed achieved at target levels and all other terms and conditions met.
10. Termination
(a) Termination by Death, Disability, or Retirement. Subject to Section 5(e), if a Participant’s employment by the Company terminates by reason of death, Disability or Retirement, or in the case of an advisory relationship if such business relationship terminates by reason of death or Disability, any Award held by such Participant, unless otherwise determined by the Committee at grant or otherwise interpreted pursuant to Section 12(l) hereof, shall be fully vested and may thereafter be exercised by the Participant or by the Participant’s beneficiary or legal representative, for a period of one (1) year following termination of employment, in the case of death or Disability, and 90 days in the case of Retirement, or such longer period as the Committee may specify at or after grant in all cases other than ISOs, or until the expiration of the stated term of such Award, whichever period is shorter; provided, that unless otherwise provided in an Award agreement, for Full-Value Awards conditioned on achievement of Performance Goals, no vesting may occur and/or no distribution may be made in the case of Retirement prior to the attainment of Performance Goals.
(b) Termination for Cause. If a Participant’s employment or service terminates for Cause, (i) all Stock Options and SARs (or portions thereof) which have not been exercised, whether vested or not, and (ii) all unvested Full-Value Awards, shall immediately be forfeited upon termination, including such Awards that are subject to performance conditions (or unearned portions thereof).
(c) Other Terminations. If a Participant’s employment or service terminates, voluntarily or involuntarily, for any reason other than death, Disability, Retirement or Cause, (i) any vested portion of Stock Options or SARs held by the Participant at the time of termination may be exercised for a period of three months (or such other period as the Committee
9


may specify at or after the time of grant) from the termination date, or until the expiration of the original term of the Stock Option or SAR, whichever period is shorter, (ii) no unvested portion of any Stock Option or SAR shall become vested, including such Awards that are subject to performance conditions (or unearned portions thereof), and (iii) all unvested Full-Value Awards, including such Awards that are subject to performance conditions (or unearned portions thereof), shall immediately be forfeited upon termination.
(d) Limitation for ISOs. No ISO may be exercised more than three months following termination of employment for any reason (including Retirement) other than death or Disability, nor more than one year following termination of employment for the reason of death or Disability (as defined in Code Section 422), or such Award will no longer qualify as an ISO and shall thereafter be, and receive the tax treatment applicable to, a NQSO. For this purpose, a termination of employment is cessation of employment, under the rules applicable to ISOs, such that no employment relationship exists between the Participant and the Company.
(e) Transfers and Leaves of Absence. The transfer of a Participant within the Company shall not be deemed a termination of employment except as required by Code Sections 422 and 409A, and other applicable laws. The following leaves of absences are not deemed to be a termination of employment:
(i) if approved in writing by the Company, for military service, sickness or any other purpose approved by the Company, and the period of absence does not exceed 90 days;
(ii) if in excess of 90 days, if approved in writing by the Company, but only if the Participant’s right to reemployment is guaranteed by statute or contract and provided that the Participant returns to work within 30 days after the end of such absence; and
(iii) subject to the restrictions of Code Section 409A and to the extent that such discretion is permitted by law, if the Committee determines in its discretion that the absence is not a termination of employment.
11. Recoupment or Recovery Policy
Any Award shall be subject to forfeiture or repayment pursuant to the terms of any applicable compensation recoupment or recovery policy adopted by the Company, Committee or Board, as thereafter amended, including any policy adopted to comply with the rules of any national securities exchange on which the Common Shares are traded or the Securities and Exchange Commission.
12. Miscellaneous Provisions
(a) Rights as a Shareholder. Except as otherwise provided herein, a Participant shall have no rights as a shareholder with respect to Awards hereunder, unless and until the Common Shares have been registered to the Participant as the owner.
(b) No Loans. No loans from the Company to Participants shall be permitted in connection with the Plan.
(c) Assignment or Transfer. Except as otherwise provided under the Plan, no Award or any rights or interests therein shall be transferable other than by will or the laws of descent and distribution. The Committee may, in its discretion, provide that an Award (other than an ISO) is transferable without the payment of any consideration to a Participant’s family member, subject to such terms and conditions as the Committee may impose. For this purpose, “family member” has the meaning given to such term in the General Instructions to the Form S-8 registration statement under the Securities Act. All Awards shall be exercisable, during the Participant’s lifetime, only by the Participant or a person who is a permitted transferee pursuant to this Section 12(c). Once awarded, the Common Shares (other than Restricted Shares) received by Participants may be freely transferred, assigned, pledged or otherwise subjected to lien, subject to the restrictions imposed by the Securities Act, Section 16 of the Exchange Act and the Company’s Insider Trading Policy, each as amended. Notwithstanding the foregoing, the Committee may, with respect to particular Awards, establish or modify the terms of the Award to allow the Award to be transferred at the request of a Participant to trusts established by a Participant or as to which a Participant is a grantor or to the spouse or lineal descendants of a Participant or otherwise for personal and tax planning purposes of a Participant. If the Committee allows such transfer, such Awards shall not be exercisable for a period of six months following the action of the Committee.
(d) Withholding Taxes. The Company shall (upon the election by the Participant) deduct from all Awards paid in cash to a Participant any taxes required by law to be withheld with respect to such Awards. Applicable withholding taxes arising with respect to Awards paid in Common Shares to a Participant shall (upon the election by the Participant) be satisfied by the Company retaining Common Shares having a Fair Market Value on the date the tax is to be determined that is not to exceed the maximum statutory tax rate in the employee’s applicable jurisdictions (rounded, if necessary, to the next lowest whole number of Common Shares); provided, however, that, subject to any restrictions or limitations that the
10


Company deems appropriate and except as may be provided otherwise in an Award Agreement, a Participant shall retain the right to elect to satisfy any such statutory minimum applicable withholding tax through cash or cash proceeds.
(e) No Rights to Awards. Neither the Plan nor any action taken hereunder shall be construed as giving any person any right to be retained in the employ or service of the Company, and the Plan shall not interfere with or limit in any way the right of the Company to terminate any person’s employment or service at any time. Except as set forth herein, no employee or other person shall have any claim or right to be granted an Award under the Plan. By accepting an Award, the Participant acknowledges and agrees that (i) the Award will be exclusively governed by the Plan, including the right of the Company to amend or cancel the Plan at any time without the Company incurring liability to the Participant (except, to the extent the terms of the Award so provide, for Awards already granted under the Plan), (ii) the Participant is not entitled to future award grants under the Plan or any other plan, and (iii) the value of any Awards received shall be excluded from the calculation of termination or other severance payments or benefits.
(f) Beneficiary Designation. To the extent allowed by the Committee, each Participant under the Plan may name any beneficiary or beneficiaries to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives all of such benefit. Unless the Committee determines otherwise, each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by the Committee and shall be effective only when received in writing by the Company during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.
(g) Fractional Shares. Fractional Common Shares shall not be issued or transferred under an Award, but the Committee may direct that cash be paid in lieu of fractional shares or may round off fractional shares, in its discretion.
(h) Unfunded Plan. The Plan shall be unfunded and any benefits under the Plan shall represent an unsecured promise to pay by the Company. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the Participant any rights that are greater than those of a general unsecured creditor of the Company.
(i) Severability. If any provision of the Plan is deemed illegal or invalid, the illegality or invalidity shall not affect the remaining provisions of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.
(j) Limitation of Liability. Members of the Board and the Committee and officers and employees of the Company who are their designees acting under the Plan shall be fully protected in relying in good faith upon the advice of counsel and shall incur no liability except for gross or willful misconduct in the performance of their duties hereunder.
(k) Successors. All obligations of the Company with respect to Awards granted under the Plan shall be binding on any successor to the Company, whether as a result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
(l) Code Section 409A Compliance. Each Award granted under the Plan is intended to be either exempt from or in compliance with the requirements of Code Section 409A and any regulations or guidance that may be adopted thereunder, including any transition relief available under applicable guidance. The Plan may be amended or interpreted by the Committee as it determines appropriate in accordance with Code Section 409A in order for the Plan and Awards to comply with Code Section 409A. If a Participant is a “specified employee” as defined in Code Section 409A at the time of the Participant’s separation from service with the Company, then solely to the extent necessary to avoid the imposition of any additional tax under Code Section 409A, the commencement of any payments or benefits under an Award shall be deferred until the date that is six months following the Participant’s separation from service (or such other period as required to comply with Code Section 409A). Notwithstanding the foregoing, the Company does not guarantee that Awards under the Plan will comply with Code Section 409A and the Committee is under no obligation to make any changes to Awards to cause such compliance.
13. Effective Date, Amendments, Governing Law and Plan Termination
(a) Effective Date. The Effective Date of the Plan is the date on which the Company’s shareholders approve the Plan at a duly held shareholder meeting.
(b) Amendments.
(i) Amendment of the Plan. The Committee or the Board may at any time terminate or amend the Plan in whole or in part, but no such action shall materially and adversely affect any rights or obligations with respect to any Awards granted prior to the date of such termination or amendment without the consent of the affected Participant, except to the extent that the Committee reasonably determines that such termination or amendment is necessary or appropriate to comply with applicable law or the rules and regulations of any stock exchange on which the Common Shares are traded or
11


to preserve any intended favorable, or avoid any unintended unfavorable, tax effects for the Company, Plan or Participants. Notwithstanding the foregoing, unless the Company’s shareholders shall have first approved the amendment, no amendment of the Plan shall be effective if the amendment would: (A) increase the maximum number of Common Shares that may be delivered under the Plan or to any one individual (except to the extent made pursuant to Section 8 hereof), (B) extend the maximum period during which Awards may be granted under the Plan, (C) add to the types of awards that can be made under the Plan, (D) modify the requirements as to eligibility for participation in the Plan, (E) permit a repricing or decrease the Exercise Price to less than the Fair Market Value on the Date of Grant of any Stock Option or SAR, except for adjustments made pursuant to Section 8, (F) materially increase benefits to Participants, or (G) otherwise require shareholder approval pursuant to the Plan or applicable law or the rules of the principal securities exchange on which Common Shares are traded.
(ii) Amendment of Awards. The Committee may amend, prospectively or retroactively, the terms of an Award, provided that no such amendment is inconsistent with the terms of the Plan or would materially and adversely affect the rights of any Participant without his or her written consent.
(c) Governing Law. To the extent not preempted by Federal law, the Plan and all Award Agreements are construed in accordance with and governed by the laws of the State of Delaware. The Plan is not intended to be governed by the Employment Retirement Income Security Act of 1974, and shall be so construed and administered.
(d) Plan Termination. No Awards shall be made under the Plan after the tenth anniversary of the Effective Date.
12
EX-101.SCH 3 atrc-20220525.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 atrc-20220525_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 5 atrc-20220525_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
May 25, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date May 25, 2022
Entity Registrant Name AtriCure, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 000-51470
Entity Tax Identification Number 34-1940305
Entity Address, Address Line One 7555 Innovation Way
Entity Address, City or Town Mason
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45040
City Area Code 513
Local Phone Number 755-4100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.001 par value
Trading Symbol ATRC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Central Index Key 0001323885
Amendment Flag false
XML 7 atrc-20220525_htm.xml IDEA: XBRL DOCUMENT 0001323885 2022-05-25 2022-05-25 0001323885 false 8-K 2022-05-25 AtriCure, Inc. DE 000-51470 34-1940305 7555 Innovation Way Mason OH 45040 513 755-4100 false false false false Common Stock, $.001 par value ATRC NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( --&NU0'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #31KM49KQY>>\ K @ $0 &1O8U!R;W!S+V-O&ULS9+! M3L,P#(9?!>7>NDT9H*C+!<0))"0F@;A%B;=%:]HH,6KW]J1AZX3@ 3C&_O/Y ML^16>Z&'@"]A\!C(8KR:7-='H?V:[8F\ (AZCT[%,B7ZU-P.P2E*S[ #K_1! M[1!X5=V 0U)&D8(96/B%R&1KM- !%0WAA#=ZP?O/T&68T8 =.NPI0EW6P.0\ MT1^GKH4+8(81!A>_"V@68J[^BQ')N<2SO4\/[\])K7+6P? M2?4:TZ]H!1T]KMEY\EMS_[!Y9))7G!?5JN"WFYJ+U;5H[CYFUQ]^%V$W&+NU M_]CX+"A;^'47\@M02P,$% @ TT:[5)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" #31KM4!WT8^QL$ 3$ & 'AL+W=O?PJKV8EE!MB)SE_/Q\?_[$9K)5^,2O.+7G+4FDN.RMK\\^>9^(5SY@Y M53F7\&2A=,8L=/72,[GF+"F#LM2COG_F94S(SG!0WIOHX4 5-A623S0Q198Q MO;GBJ5I?=H+.^XTGL5Q9=\,;#G*VY%-N_\@G&GI>I9*(C$LCE"2:+RX[H^#S M%0U=0/G&GX*OS5Z;N*',E7IQG;ODLN,[(I[RV#H)!I=7/N9IZI2 X]^=:*?Z M31>XWWY7ORT'#X.9,\/'*GT6B5U==OH=DO %*U+[I-9?^6Y D=.+56K*OV2] M?3<,.R0NC%79+A@(,B&W5_:V2\1>0,\_$$!W ;3DWOY027G-+!L.M%H3[=X& M-=Z5D>$#R6L4%5(\ELTW.FP:( MA_=/OB$08041'@E<:>86;Y=,+:2-*$W& MJI!6;^":--+BXM/H53_\8 MGAE[(W<)5)M8B+A,&T*'*_;"D^ B]'M^A.!=5'@7Q^"-DD1S8[KO#?(=WB./ MLG$6<<7S*(J@0*1ZW0[SF6T0SL"OO=#_$.G8]:#F9FHM&ST2E[MG1DD,;,^D M@P^!5:MAHM6KD'%C#ELT'[]B:+5S!_1#:!-E+$O)7R(_N$1;%,/(#[%E$=2? M@ W\7+^1K!9.8R""T1!#P.I/P,![M[?50PYF:R4Q!RC102J_B0,?#0UM?L' MN&T_:V$MEY"8+"ODSB],(Q4NM&"IX1A2[?L![LU3E8I86"&7Y![*6PN6-O+@ M*JT\MJUDM=\'N#W_C^S.F +( M6@%QV5; VO$#W*!GPL*W42U(0'^;_TZF/"Z@WC:-3+B2JT]P^*E5\4N7_'KJ M^P')F2:O+"TP5EJ;/L5=>J99XFINNLGFJK'B6@1&LZW9"U"#Z/I]>@'QK2W,3_*WF\RKI1,-DYHBV!;D=': MW6F+NT/E:[#5.RCZ-_*--]/@&K -"WJTU^]C&QU:^SS%+7H$JS$I5^1MRI:- M/+C P>QX>T<\=UR^9VX^#$GY H3\TW-P:;T]@6X[5N7EJ6^N+)PAR^8*3NU< MNQ?@^4(I^]YQ!\GJ_P##_P!02P,$% @ TT:[5)^@&_"Q @ X@P T M !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV M!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-S MS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L. MIM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ# M%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6 M#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#H MG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5B'_2^FO-CT1=X=-8T\O1!BEHK M'O;^RPF+-9O\R-%8\>2SP:0)P:?EA6;/CO9NFJ:]PSLM_D/.? MK7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'- MM[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?] MK-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7 MCX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L M"]CL0/YX'IBIN$^:0ERHY_U=3_ 102P,$% @ TT:[5)>* MNQS $P( L !?3T\$MP>:4#M.*2VBZD8_1!2:5K5N %( MMB6/:(7->=I3W;+T]! M;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B M':5_'B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q8;!EK '$NW2:9;/46PQF MN1BUMIS> A(H!"DHV1%[A$O\G7D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#BG/]3(U45%K"FHO409.B1 MP74&0ZRQB28)UD-N5G0&[O+H YMRR"9JZJ8IGJ,.>%,.]D9/)508H'Q3F:B\ M]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48Y0]02P,$% @ TT:[5"0> MFZ*M ^ $ !H !X;"]?+7_OR4Z?:!1W M;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9 MHIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJ MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( --& MNU1ED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"% MKQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/ M$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4 MZ]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N M6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC M JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@A MLO7L^T%.6X.^D>\ K M @ $0 @ &O 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 M " #31KM4F5R<(Q & "<)P $P @ '- 0 >&PO=&AE M;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( --&NU0'?1C[&P0 !,0 8 M " @0X( !X;"]W;W)K&PO&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #31KM499!YDAD! #/ P M$P @ %I$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .."0 ) #X" "S$P ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.atricure.com/role/Cover Cover Cover 1 false false All Reports Book All Reports atrc-20220525.htm atrc-20220525.xsd atrc-20220525_lab.xml atrc-20220525_pre.xml exhibit101-2014stockincent.htm http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "atrc-20220525.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "atrc-20220525.htm" ] }, "labelLink": { "local": [ "atrc-20220525_lab.xml" ] }, "presentationLink": { "local": [ "atrc-20220525_pre.xml" ] }, "schema": { "local": [ "atrc-20220525.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "atrc", "nsuri": "http://www.atricure.com/20220525", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "atrc-20220525.htm", "contextRef": "ia60ef8ad41ae4429946f7a0283f55a53_D20220525-20220525", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.atricure.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "atrc-20220525.htm", "contextRef": "ia60ef8ad41ae4429946f7a0283f55a53_D20220525-20220525", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.atricure.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001323885-22-000063-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001323885-22-000063-xbrl.zip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

YVZC4 "78V#G@:&3GGOEWW^N5^ )*Z_0-)8T8C*ED%V!^G@AB_V,3)B M.)Y6O/]]UB62]JQW6K,#N35)(W5%VJ1889TG+W9A?[ M4E%-L7!LSDTQ=,P_.8O3:.:-%K_M.E8O,GN?$L.A'68N.R\!!UIQ-LB5@(G-\ MZC6\5WW'TF<[4%O S;A-ANB-K>CO4LP9Y!\HZJU^=HNB=![D#ND7V=RFR(/8R0VN7310':0 MV(@\AJ=K>WE' AG#(L_Q IV;CJCYF8\".[(A':PDF%ZJA-![Q#+J)81,Y;B% M#+*"MZ"DCI037MDL7-)L.?CO#[6V(_ME6#P0S33 IJLQBQ8M M4(<=ZW:= 0% T<_1IJ^<=O)^*'N-;-T]1_VDWU%_,"J2%?QG6L^RG_\_4$L! M A0#% @ TT:[5$P)N(IT&P 5/( !$ ( ! &%T M'-D4$L! A0#% @ MTT:[5#;9!9I3"@ $5T !4 ( !/!X &%T